Strides Pharma Science Limited (BSE: 532531, NSE: STAR, Company or Strides), a global pharmaceutical company, today announced that Dr. R. Ananthanarayanan(Ananth) has decided to depart as Managing Director (MD) and Chief Executive Officer (CEO) of Strides, effective March 31, 2022, to pursue his personal interests outside the organization. Since January 2020, Ananth has been spearheading Strides and has been driving the strategic decisions around the future design of the organization. The Board of Directors of the Company (Board) accepted Ananth's resignation and thanked him for his leadership, commitment, enthusiasm, and motivation during his tenure at Strides in a challenging global operating environment. Consequently, Arun Kumar, Founder, will return to Strides in an executive role and assume the position of Executive Chairperson and Managing Director(MD) effective April 7, 2022. Commenting on the updates, Arun Kumar remarked, "We thank Ananth for his leadership during his tenure at Strides in a tough global operating environment. Ananth has been closely working with the Board to recalibrate the growth and profitability of the Company and our priority is to continue building on those strategic and operational initiatives. The Company remains committed to enabling a fast turnaround of its business performance and delivering sustainable outcomes." Shares of Strides Pharma Science Limited was last trading in BSE at Rs. 352.65 as compared to the previous close of Rs. 357.50. The total number of shares traded during the day was 27455 in over 968 trades. The stock hit an intraday high of Rs. 363.35 and intraday low of 352.00. The net turnover during the day was Rs. 9804229.00.

Website Created & Maintained by : Chennai Scripts West Mambalam, Chennai - 600 033, Tamil Nadu, India